Literature DB >> 22759317

Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review.

Bhavan Prasad Rai1, Mike Shelley, Bernadette Coles, Bhaskar Somani, Ghulam Nabi.   

Abstract

Surgical management of upper urinary tract transitional cell carcinoma (UUT-TCC) has significantly changed over the past two decades. Data for several new surgical techniques, including nephron-sparing surgery (NSS), is emerging. The study systematically reviewed the literature comparing (randomised and observational studies) surgical and oncological outcomes for various surgical techniques MEDLINE, EMBASE, Cochrane Library, CINAHL, British Nursing Index, AMED, LILACS, Web of Science, Scopus, Biosis, TRIP, Biomed Central, Dissertation Abstracts, ISI proceedings, and PubMed were searched to identify suitable studies. Data were extracted from each identified paper independently by two reviewers (B.R. and B.S.) and cross checked by a senior member of the team. The data analysis was performed using the Cochrane software Review manager version 5. Comparable data from each study was combined in a meta-analysis where possible. For dichotomous data, odds ratios with 95% confidence intervals (CIs) were estimated based on the fixed-effects model and according to an intention-to-treat analysis. If the data available were deemed not suitable for a meta-analysis it was described in a narrative fashion. One randomised control trial (RCT) and 19 observational studies comparing open nephroureterectomy (ONU) and laparoscopic NU (LNU) were identified. The RCT reported the LNU group to have statistically significantly less blood loss (104 vs 430 mL, P < 0.001) and mean time to discharge (2.30 vs 3.65 days, P < 0.001) than the ONU group. At a median follow-up of 44 months, the overall 5-year cancer-specific survival (CSS; 89.9 vs 79.8%) and 5-year metastasis-free survival rates (77.4 vs 72.5%) for the ONU were better than for LNU, respectively, although not statistically significant. A meta-analysis of the observational studies favoured LNU group for lower urinary recurrence (P < 0.001) and distant metastasis. The meta-analyses for local recurrence for the two groups were comparable. One retrospective study comparing ONU with a percutaneous approach for grade 2 disease reported no significant differences in CSS rates (53.8 vs 53.3 months). Three retrospective studies compared NSS and radical NU, and reported no significant differences in overall CSS and recurrence-free survival between the two approaches. Five retrospective studies compared various techniques of en bloc excision of the lower ureter. No technique was reported to be better (operative and oncological) than any other. This review concludes that there is a paucity of good quality evidence for the various surgical approaches for UUT-TCC. The techniques have been assessed and reported in many retrospective single-centre studies favouring LNU for better perioperative outcomes and comparable oncological safety. The reported observational studies data is further supported by one RCT.
© 2012 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2012        PMID: 22759317     DOI: 10.1111/j.1464-410X.2012.11341.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  24 in total

1.  Comparison of post-operative intravesical recurrence and oncological outcomes after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.

Authors:  Lujia Zou; Limin Zhang; Hu Zhang; Haowen Jiang; Qiang Ding
Journal:  World J Urol       Date:  2014-04       Impact factor: 4.226

2.  Laparoscopic nephroureterectomy in a patient with a left ventricular assist device.

Authors:  Jasmir G Nayak; Christopher W White; Wayne Nates; Rajan Sharda; David Horne; Kam Kaler; Mark Lytwyn; Hilary P Grocott; Darren H Freed; Thomas McGregor
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

Review 3.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

4.  Transurethral electric coagulation combined with retroperitoneal laparoscopic nephroureterectomy for upper urinary urothelial carcinoma.

Authors:  Jiantao Wang; Shengqiang Yu; Changping Men; Chunhua Lin; Zhiyu Zhang; Zhenli Gao; Yulian Zhang; Ke Wang
Journal:  Int Surg       Date:  2015-03

5.  Socio-economic deprivation and outcomes following radical nephroureterectomy for clinically localized upper tract transitional cell carcinoma.

Authors:  R Mehta; A S Gillan; Z Y Ming; B P Rai; D Byrne; G Nabi
Journal:  World J Urol       Date:  2014-03-12       Impact factor: 4.226

6.  Segmental ureterectomy is not inferior to radical nephroureterectomy for either middle or distal ureter urothelial cell carcinomas within 3.5 cm.

Authors:  Chen Fang; Xin Xie; Tianyuan Xu; Wei He; Hongchao He; Xiaojing Wang; Yu Zhu; Zhoujun Shen; Yuan Shao
Journal:  Int Urol Nephrol       Date:  2017-03-25       Impact factor: 2.370

Review 7.  Pictorial review of tips and tricks for ureteroscopy and stone treatment: an essential guide for urologists from PETRA research consortium.

Authors:  Bhaskar K Somani; Achilles Ploumidis; Athanasios Pappas; Steeve Doizi; Omikunle Babawale; Laurian Dragos; Emre Sener; Michele Talso; Tzevat Tefik; Peter Kronenberg; Esteban Emiliani; Luca Villa; Guido Kamphuis; Silvia Proietti; Olivier Traxer
Journal:  Transl Androl Urol       Date:  2019-09

Review 8.  Oncologic outcomes obtained after laparoscopic, robotic and/or single port nephroureterectomy for upper urinary tract tumours.

Authors:  Maria J Ribal; J Huguet; A Alcaraz
Journal:  World J Urol       Date:  2012-10-25       Impact factor: 4.226

9.  Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.

Authors:  Hyung Suk Kim; Ja Hyeon Ku; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim
Journal:  World J Urol       Date:  2015-10-23       Impact factor: 4.226

Review 10.  The role of systemic chemotherapy in management of upper tract urothelial cancer.

Authors:  Bishoy A Gayed; Gregory R Thoreson; Vitaly Margulis
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.